(PRBuzz.com) May 7, 2013 -- Because of the growing fitness and health problems, the society needs rather number of fitness professionals and health experts that can guide the individuals in the right direction. To do so individuals need quality, certified and expert professionals that could drive them to the right path and that is on the way to get rid of the fitness and health issues and get an amazing healthy life yet again.

National Exercise & Sports Trainers Association (NESTA) has been working very closely with the fitness industry and is considered to be one of the very best fitness schools that have produced countless numbers of certified fitness and wellness professionals. On the other hand Wexford University, the upper division of NESTA, offers degree programs. Now both institutes, offers no path to a successful career in fitness and wellness industry with one offering certificate courses while other offers degree programs and with the combination of these two one can have a successful career in the industry without any doubts. John Spencer Ellis, founder of NESTA and Wexford University said, "Education is a key to success in any field, and NESTA and Wexford together offer the best fitness education available today."

NESTA has been offering personal trainer certifications from quite some time now and NESTA's personal training certification is considered to be one of the best because of the teaching methodology and expert faculty at the NESTA. NESTA certified fitness trainers and wellness experts have a positive reputation in the fitness industry, which is undoubtedly well deserved. "The more you know, the more you can grow your business, find the best clients and succeed in the career of your dreams. We're thrilled to bring NESTA and Wexford together to help more people enhance their fitness knowledge and credentials." Added John Spencer.

Wexford University has recently emerged to be the top fitness university that offers fitness degree, fitness trainer degree, applied sports Psychology degree and many others. Wexford's fitness training degree are among the top notch programs at the university and anybody who wants to become a personal trainer and wants to start a personal training career then Wexford is the perfect place to start off. And obviously now with the NESTA's collaboration, any individual who sign up for an associate arts degree in a fitness training program at Wexford University will also earn a NESTA personal fitness trainer certification as well as the part of the degree.

About NESTA:

NESTA was founded by John Spencer Ellis in 1992 and right now it has more than 55,000 members in 55 countries and it is one of the largest fitness associations in the world.

About Wexford University:

Wexford University is an online fitness and wellness institute that offers degree programs in health, fitness, wellness, sports psychology and many other fields.

NESTA Fitness Association and Wexford University
Rancho Santa Margarita, CA
Toll Free 1-877-573-6474

(PRBuzz.com) May 8, 2013 -- North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017

The North American radiopharmaceuticals market was valued at $1.9 billion in 2012 and is poised to reach $2.7 billion by 2017 at a CAGR of 7.2%.

A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as North America between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 in Canada is, however, a major threat for manufacturers.

Full Report Details at
- http://www.fastmr.com/prod/591786_north_american_nuclear.aspx?afid=101

The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects; radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy.

The U.S. is the dominant market for diagnostic radioisotopes with more than 80% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Triad Isotopes, Inc. (U.S.).

The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 90% to the North American revenue.

Scope of the Report

The radioisotope and stable isotope markets have been segmented according to the type of isotope, and applications. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (U.S. and Canada) to provide in-depth information on the country basis.

North American Radiopharmaceuticals Market

Diagnostic
SPECT
Tc-99m
Tl-201
Ga-67
I-123
Others
PET
F-18
Rb-82
Others
Therapy
Beta emitters
I-131
Sm-153
Re-186
Y-90
Lu-177
Others
Alpha emitters
Brachytherapy
Cs-131
I-125
Pd-103
Ir-192
Others
North American Enriched Stable Isotopes Market

Deuterium
Oxygen-18
Carbon-13
Nitrogen-15
Others
North American Radiopharmaceutical and Stable Isotope Markets, By Country

U.S.
Canada

Partial Table of Contents:

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 DEFINITION OF RADIOPHARMACEUTICALS
3.2 EVOLUTION
3.3 MARKET SEGMENTATION
3.3.1 RADIOPHARMACEUTICALS
3.3.2 STABLE ISOTOPES
3.4 MARKET DYNAMICS
3.4.1 DRIVERS
3.4.1.1 Increasing incidence of cancer and cardiac ailments boosts the demand for radiopharmaceuticals
3.4.1.2 Increasing use of SPECT and PET scans results in the rise of radiopharmaceutical usage
3.4.1.3 Rising awareness of radiopharmaceuticals to spur growth
3.4.1.4 Ready availability of radiopharmaceuticals from cyclotrons to goad the growth

3.4.2 RESTRAINTS
3.4.2.1 Shorter half-life of radiopharmaceuticals to restrict usage
3.4.2.2 High capital demand to limit the buying of scanners
3.4.2.3 Stringent regulatory guidelines and GMP to negatively impact growth
3.4.2.4 Competition from conventional diagnostic procedures
3.4.3 OPPORTUNITIES
3.4.3.1 Ample number of potential radioisotopes in the pipeline
3.4.3.2 Alpha radioimmunotherapy-based targeted cancer treatment
3.4.3.3 Alternative diagnostic radiopharmaceuticals solution
3.4.3.4 Cyclotron-based production
3.4.3.5 Neurological application
3.4.4 THREAT
3.4.4.1 Shutdown of nuclear reactors impacts the production of radioisotopes
3.5 WINNING IMPERATIVES
3.5.1 INVESTMENT TO ENCOURAGE NEW RADIOISOTOPES AND NOVEL APPLICATIONS
3.5.2 SHIFT TOWARDS LEU BASED MO-99 PRODUCTION
3.6 BURNING ISSUES
3.6.1 HIGH COST OF PET CAMERAS
3.6.2 SHORTAGE IN SUPPLY OF TECHNETIUM-99M
3.7 SUPPLY AND DEMAND ANALYSIS OF TECHNETIUM-99M
3.8 REGULATORY AFFAIRS
3.8.1 U.S.
3.8.1.1 FDA Approval Process
3.8.1.2 Transportation
3.8.1.3 Reimbursement scenario
3.8.2 CANADA
3.8.2.1 Nuclear Safety and Control Act
3.8.2.2 Transportation
3.8.2.3 Licensing
3.9 MARKET SHARE ANALYSIS
3.9.1 RADIOPHARMACEUTICALS MARKET
3.9.2 ENRICHED STABLE ISOTOPES MARKET
4 NORTH AMERICAN RADIOPHARMACEUTICALS MARKET, BY ISOTOPE
4.1 INTRODUCTION
4.2 DIAGNOSTIC ISOTOPES
4.2.1 OPPORTUNITY MATRIX
4.2.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) RADIOPHARMACEUTICALS
4.2.2.1 Technetium-99m (Tc-99m)
4.2.2.1.1 Tc-99m to decide growth trend of SPECT radioisotopes
4.2.2.1.2 Factors affecting Technetium-99m market
4.2.2.1.2.1 Technetium can combine with 31 different carrier molecules
4.2.2.1.2.2 Lack of availability of technetium
4.2.2.2 Thallium-201 (Tl-201)
4.2.2.2.1 Tl-201 is a potential substitute for Tc-99m
4.2.2.3 Gallium-67 (Ga-67)
4.2.2.3.1 Fluorine-18 might seize Ga-67 market share in the near future
4.2.2.4 Iodine (I-123)
4.2.2.5 Others
4.2.3 POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS
4.2.3.1 Fluorine-18
4.2.3.1.1 FDG
4.2.3.1.2 Florbetapir
4.2.3.1.3 Factors affecting Fluorine-18 market
4.2.3.1.3.1 Increasing availability of PET machines
4.2.3.1.3.2 Rise in PET procedures increases demand for FDG
4.2.3.1.3.3 High generation costs of FDG

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=591786&dt=t&afid=101

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- Spine Smith, LP (SpineSmith) provides surgical implants for the spine and orthopedic markets. It develops and sells synthetic implants and biologics that are used in regeneration of tissue of the spine, surgical fixation and correction of the spine. The products offered by the company are classified into three segments, namely, the Hardware Technologies, Regenerative Technologies and Pre-Surgical Orthopedic Conditioning. The company's products are sold under the brand names of CEQUENCE, PEEK, WAVE, CYNCH, CIMPLICITY and VisuALIF. The company's products include cervical interbody fusion devices, anterior lumbar interbody fusion devices, vertebral body replacement and intervertebral body fusion devices, anterior cervical plate systems, transforaminal lumbar interbody fusion devices, and transforaminal posterior lumbar interbody fusion devices. Its products also comprise regenerative cell products for orthopedics and spinal procedures; and whole-body advanced vibration therapy devices for advance healing applications. In addition, the company is into the development, testing, and regulatory processing of facet fixation devices, soft tissue anchors, biologically active artificial discs, cervical and lumbar disc injection therapies, proprietary disc injection devices, distraction pin aspiration devices, in situ fusion w/ natural disc properties, and biologically enhanced implants. Spine Smith is headquartered in Austin, Texas, the US.

Full Report Details at
- http://www.fastmr.com/prod/592068_spine_smith_lp_product_pipeline_analysis_2013.aspx?afid=101

This report is a source for data, analysis and actionable intelligence on the Spine Smith, LP portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.
* Exploit M&A opportunities by identifying market players with the most innovative pipeline.
* Develop market-entry and market expansion strategies.
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Develop competition strategies by identifying the status and likely launch of your competitors' pipeline products through review of the clinical trials, stage and phase of development, etc.
* Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Spine Smith, LP - Business Description
Key Facts
Spine Smith, LP - Major Products and Services
Spine Smith, LP Pipeline Products by Equipment Type
Spine Smith, LP Pipeline Products by Development Stage
Spine Smith, LP Pipeline Products by Therapy Area
Allograft Infusion Device
Allograft Infusion Device Product Status
Allograft Infusion Device Product Description
Aspiration Device
Aspiration Device Product Status
Aspiration Device Product Description
Biologic Graft Enhancement System
Biologic Graft Enhancement System Product Status
Biologic Graft Enhancement System Product Description
Closed VisuALIF
Closed VisuALIF Product Status
Closed VisuALIF Product Description
Combination Cervical Interbody Device
Combination Cervical Interbody Device Product Status
Combination Cervical Interbody Device Product Description
Mechanical Cervical Disc
Mechanical Cervical Disc Product Status
Mechanical Cervical Disc Product Description
Orthopedic Scaffold
Orthopedic Scaffold Product Status
Orthopedic Scaffold Product Description
Posterior Lumbar Interbody Fusion Device
Posterior Lumbar Interbody Fusion Device Product Status
Posterior Lumbar Interbody Fusion Device Product Description
Spine Smith, LP - Key Competitors
Spine Smith, LP - Key Employees
Spine Smith, LP - Key Employee Biographies
Spine Smith, LP - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Spine Smith, LP, Recent Developments
Jan 17, 2012: SpineSmith Adds Dr Matthew Murphy To R&D Team
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Spine Smith, LP, Key Facts
Spine Smith, LP Key Pipeline Products by Equipment Type
Spine Smith, LP Key Pipeline Products by Therapy Area
Spine Smith, LP Key Pipeline Products by Development Stage
Spine Smith, LP, Key Facts
Spine Smith, LP, Major Products and Services
Spine Smith, LP Number of Pipeline Products by Equipment Type
Spine Smith, LP Pipeline Products by Equipment Type
Spine Smith, LP Number of Pipeline Products by Development Stage
Spine Smith, LP Pipeline Products by Development Stage

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=592068&dt=t&afid=101

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- Universal Biosensors, Inc. (UBI) is an Australian medical diagnostic company. The company develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company manufactures test strips for LifeScan, Inc.'s OneTouch Verio and blood glucose testing device. UBI's key focus areas includes blood glucose testing, coagulation testing, and other electromechanical cell based test. Its in vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS), located in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.

Full Report Details at
- http://www.fastmr.com/prod/592051_universal_biosensors_inc_ubi_product_pipeline.aspx?afid=101

The strategic intent of the company is to extend its electrochemical cell technology and enter into collaborative arrangements with other life sciences companies for the development and commercialization of specific tests for specific fields.

This report is a source for data, analysis and actionable intelligence on the Universal Biosensors, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.
* Exploit M&A opportunities by identifying market players with the most innovative pipeline.
* Develop market-entry and market expansion strategies.
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Develop competition strategies by identifying the status and likely launch of your competitors' pipeline products through review of the clinical trials, stage and phase of development, etc.
* Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.

Companies Mentioned in this Report: Universal Biosensors, Inc. (UBI)

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Universal Biosensors, Inc. - Business Description
Key Facts
Universal Biosensors, Inc. - Major Products and Services
Universal Biosensors, Inc. Pipeline Products by Equipment Type
Universal Biosensors, Inc. Pipeline Products by Development Stage
Universal Biosensors, Inc. Pipeline Products by Therapy Area
C-Reactive Protein Test
C-Reactive Protein Test Product Status
C-Reactive Protein Test Product Description
DNA/RNA Blood Glucose Test
DNA/RNA Blood Glucose Test Product Status
DNA/RNA Blood Glucose Test Product Description
DNA/RNA PT/INR Testing
DNA/RNA PT/INR Testing Product Status
DNA/RNA PT/INR Testing Product Description
Handheld POC Coagulation Testing System - Ambulatory Care
Handheld POC Coagulation Testing System - Ambulatory Care Product Status
Handheld POC Coagulation Testing System - Ambulatory Care Product Description
Handheld POC Coagulation Testing System - Hospital POC
Handheld POC Coagulation Testing System - Hospital POC Product Status
Handheld POC Coagulation Testing System - Hospital POC Product Description
Immunoassay Test - D-Dimer
Immunoassay Test - D-Dimer Product Status
Immunoassay Test - D-Dimer Product Description
Universal Biosensors, Inc. - Key Competitors
Universal Biosensors, Inc. - Key Employees
Universal Biosensors, Inc. - Key Employee Biographies
Universal Biosensors, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Universal Biosensors, Inc., Key Facts
Universal Biosensors, Inc. Key Pipeline Products by Equipment Type
Universal Biosensors, Inc. Key Pipeline Products by Therapy Area
Universal Biosensors, Inc. Key Pipeline Products by Development Stage
Universal Biosensors, Inc., Key Facts
Universal Biosensors, Inc., Major Products and Services
Universal Biosensors, Inc. Number of Pipeline Products by Equipment Type
Universal Biosensors, Inc. Pipeline Products by Equipment Type
Universal Biosensors, Inc. Number of Pipeline Products by Development Stage
Universal Biosensors, Inc. Pipeline Products by Development Stage
Universal Biosensors, Inc. Number of Pipeline Products by Therapy Area

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=592051&dt=t&afid=101

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- C. R. Bard, Inc. (Bard) is a multinational medical device company. It carries out the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. It offers life-enhancing medical technologies in the areas of Vascular, Urology, Oncology and Surgical Specialty products. The company offers its wide range of products to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company conducts its operations across Americas, Europe, Asia pacific, the Middle East and Africa. It has international manufacturing facilities in Puerto Rico, Germany, France, Belgium, Mexico and Malaysia. Bard is headquartered in New Jersey, the US.

Full Report Details at
- http://www.fastmr.com/prod/592032_c_r_bard_inc_bcr_product_pipeline_analysis_2013.aspx?afid=101

The company seeks to build its position in the marketplace through internal development, partnerships, strategic alliances and acquisition of complementary businesses, technologies and products. As part of its strategy, Bard recently acquired Lutonix, Inc., Medivance, Inc., and ClearStream Technologies Group plc.

This report is a source for data, analysis and actionable intelligence on the C. R. Bard, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.
* Exploit M&A opportunities by identifying market players with the most innovative pipeline.
* Develop market-entry and market expansion strategies.
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Develop competition strategies by identifying the status and likely launch of your competitors' pipeline products through review of the clinical trials, stage and phase of development, etc.
* Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
C. R. Bard, Inc. - Business Description
Key Facts
C. R. Bard, Inc. - Major Products and Services
C. R. Bard, Inc. Pipeline Products by Equipment Type
C. R. Bard, Inc. Pipeline Products by Development Stage
C. R. Bard, Inc. Pipeline Products by Therapy Area
C. R. Bard, Inc. Pipeline Products by Trial Phase
C. R. Bard, Inc. Pipeline Products by Milestone Summary
Anti-Microbial Titanium PowerPort
Anti-Microbial Titanium PowerPort Product Status
Anti-Microbial Titanium PowerPort Product Description
Anti-Microbial Titanium PowerPort Product Patent Details
Bard Denali Retrievable Inferior Vena Cava Filter System
Bard Denali Retrievable Inferior Vena Cava Filter System Product Status
Bard Denali Retrievable Inferior Vena Cava Filter System Product Description
Bard Denali Retrievable Inferior Vena Cava Filter System Clinical Trial
Bard Denali Retrievable Inferior Vena Cava Filter System Product Patent Details
BARD HD MESH Ablation System
BARD HD MESH Ablation System Product Status
BARD HD MESH Ablation System Product Description
BARD HD MESH Ablation System Product Milestone
BARD HD MESH Ablation System Clinical Trial
BARD HD MESH Ablation System Product Patent Details
COVERT PowerPICC
COVERT PowerPICC Product Status
COVERT PowerPICC Product Description
COVERT PowerPICC Product Patent Details
Dual Lumen PowerPort
Dual Lumen PowerPort Product Status
Dual Lumen PowerPort Product Description
ENCOMPASS
ENCOMPASS Product Status
ENCOMPASS Product Description
ENCOMPASS Product Patent Details
FAZER Freehand Stereotactic System
FAZER Freehand Stereotactic System Product Status
FAZER Freehand Stereotactic System Product Description
FLUENCY PLUS Endovascular Stent Graft
FLUENCY PLUS Endovascular Stent Graft Product Status
FLUENCY PLUS Endovascular Stent Graft Product Description
FLUENCY PLUS Endovascular Stent Graft Clinical Trial
FLUENCY PLUS Endovascular Stent Graft Product Patent Details
Inspire Vision
Inspire Vision Product Status
Inspire Vision Product Description
Internal Jugular Placement Catheter
Internal Jugular Placement Catheter Product Status
Internal Jugular Placement Catheter Product Description

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=592032&dt=t&afid=101

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- BMI's Thailand Defence & Security Report for Q2 2013 examines the country's strategic position in South East Asia and the wider world. It provides an overview of the contemporary geopolitical challenges facing the country, and the challenges it may face in the future.

The report examines the trends occurring in the country's current and future defence procurement, and the order of battle across its armed forces. The report's general conclusion is that the relative political and social calm that currently prevails in Thailand looks set to continue in the short to medium term. However, the process of reconciliation that started in 2011-12 by the royalist-military elite and the elected Puea Thai administration of Yingluck Shinawatra appear to have stalled over the highly contentious issue of whether to allow former leader Thaksin Shinawatra, Yingluck's brother, to return to Thailand. More broadly, the deep divisions that plunged Thailand into civil strife in 2010 remain, and the country remains prone to further instability. The passing of Thailand's long-serving and increasingly frail monarch, King Bhumibol Adulyadej, looms on the horizon as a potentially destabilising event that could plunge Thailand back into turmoil.

Full Report Details at
- http://www.fastmr.com/prod/589248_thailand_defence_security_report_q2_2013.aspx?afid=101

However, Q1 2013 witnessed an unexpected breakthrough in the country's long-running insurgency in the deep south as the government announced that it was due to open peace talks with the Barisan Revolusi Nasional (BRN), one of a number of insurgent Malay-Muslim groups. On the one hand, this was a positive step, signalling that Bangkok is finally willing to pursue alternatives to its failed military-led approach to handling the southern unrest. On the other hand, critics pointed out that the BRN is only one of around 10 militant groups operating in the south, and that talking to one group will not ensure the participation of the others. Nonetheless, the first round of talks, due to begin in Kuala Lumpur on 28 March, offers the chance of a new beginning, even if a lasting peace agreement remains a very long way off.

Thailand's long-standing dispute with Cambodia is also set to return to the agenda. Though the two countries have refrained from violence along their disputed border in recent months, the International Court of Justice is set to convene a hearing in April to address the issue of the violence surrounding Preah Vihear temple, which is at the centre of the dispute. The hearing comes at Cambodia's request, which is seeking clarifications on the 1962 ICJ ruling which confirmed Cambodian sovereignty over Preah Vihear. However, it could be that the proceedings only serve to stoke resentment between the two neighbours, rather than produce a lasting solution.

Over the last quarter BMI has revised the following forecasts/views:

* The prospect of peace talks between the Thai government and Muslim-Malay insurgents is discussed in detail.
* The latest military procurement programmes are also discussed. The Thai programme currently generating the most international interest is the navy's requirement for two new frigates worth up to US$1bn. China has made a serious bid for the contract, offering three Type 054 frigates for under the US$1bn budget. The US's Lockheed Martin also appears ready to make a strong case, with reports suggesting that it is set to offer its new Littoral Combat Ship to the Thais.
* The Thai defence budget has also continued to rise, topping US$6bn again in 2013.

Report Table of Contents:

Executive Summary
SWOT Analysis
- Thailand Security SWOT
- Thailand Defence Industry SWOT
- Thailand Political SWOT
- Thailand Economic SWOT
- Thailand Business Environment SWOT
Global Political Outlook
- Table: Elections In 2013
South East Asia Security Overview
- The Strategic Outlook For The 2010s
- Challenges And Threats To Stability And Security
- Main Islamist Militant Groups In South East Asia
- Other Regional Threats
- Sino-US Rivalry In South East Asia
- Sino-Japanese Rivalry In South East Asia
- The Outlook For South East Asia
Security Risk Analysis
- Table: Asia Pacific Regional Security Ratings
- Table: Asia Pacific State Vulnerability To Terrorism Index
- Thailand's Security Risk
Political Overview
- Domestic Politics
- Long-Term Political Outlook
Security Overview
- Table: Thai Muslim Insurgents
- BRN-K
- GMIP/PULO
- Bilateral And Multilateral Security Relations
- Drugs Trade
Armed Forces And Government Spending
- Armed Forces
- International Deployments
- Weapons Of Mass Destruction
Market Overview
- Arms Trade Overview
- Procurement Trends And Developments
- Competitive Landscape
- Table: Thailand's Military Key Players
Industry Forecast Scenario
- Armed Forces
- Table: Thailand's Armed Forces, 2001-2008 ('000 Personnel Unless Otherwise Stated), 2001-2008
- Table: Thailand's Available Manpower For Military Services, 2010-2017 (aged 16-49, unless otherwise stated)
- Defence Expenditure
- Table: Thailand's Government Defence Expenditure, 2010-2017
- Table: Thailand's Defence Expenditure Scenario - Changing % Of GDP, 2010-2017 (US$mn)
- Defence Trade
- Table: Thailand's Defence Exports, 2010-2017 (US$mn)
- Table: Thailand's Defence Imports, 2010-2017 (US$mn)
- Table: Thailand's Defence Trade Balance, 2010-2017 (US$mn)
Macroeconomic Forecast
- Table: Thailand - Economic Activity
Company Profiles
- Loxley
- Minebea
- Thai-Italian Interarms Company
BMI Methodology
- How We Generate Our Industry Forecasts
- Defence Industry
- Sources

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- We forecast Russia's mining industry value to reach US$160bn by 2017, growing at an annual average rate of 1.3% from 2011 levels. We believe strong growth in 2010 and 2011 will be followed by years of slowing growth as palladium and platinum production in the country experience modest increases over the coming years. Nevertheless, we have a positive view on the Russian mining industry given the country's vast unexplored mineral resources. The coal sector is promising as the government plans to invest RUB3.7trn (US$120bn) in the sector between 2012 and 2030.

The government will maintain a strong influence on the industry. For example, total palladium supply from Russia is complicated by palladium sales from government stockpiles, which are very large relative to primary production. Foreign firms are also restricted in investing in the industry. Companies seeking to develop a 'strategic resource', defined as a region with more than 1.6mn ounces of gold and 500kt ('000 tonnes) of copper, must seek permission from a government commission. Diamonds, uranium, cobalt, nickel, lithium, the platinum group metals (PGM), tantalum and niobium cannot be mined by foreign firms. In practice, legal obstacles to foreign investment have prevented large overseas firms from developing exploration projects, and smaller reserves are relatively unattractive given the bureaucratic problems. We expect the regulatory structure to remain favourable to domestic miners with obstacles to foreign investment remaining. Endemic corruption will likely further dissuade foreign investment.

Full Report Details at
- http://www.fastmr.com/prod/589231_russia_mining_report_q2_2013.aspx?afid=101

Looking at production, we expect the platinum and palladium sectors to experience modest growth, growing at an annual average rate of 1.7% and 1.0% respectively. Production growth in platinum will be coming from Amur Minerals. The largest producer Norilsk Nickel will not be contributing to production growth in the PGM sector as the miner reduced its target output for palladium in 2013.

Report Table of Contents:

BMI Industry View
SWOT
Market Overview
- Table: Russia - Mining Industry Value & Production Forecasts
Industry Forecast
- Table: Russia - Largest Platinum Projects
- Table: Russia - Platinum Production Forecast
- Gold: Regulatory Hurdles To Restrict Growth
- Table: Russia - Gold Production Forecasts
- Coal: Kuzbass To Underpin Production Growth
- Table: Russia - Coal Production Forecasts
- Nickel: Subdued Growth Ahead
- Table: Russia - Largest Nickel Projects
- Table: Russia - Nickel Production Forecasts
- Palladium: Production To Remain Flat
- Table: Russia - Largest Palladium Projects
- Table: Russia - Palladium Production Forecasts
- Iron Ore: Little Impetus For Output Growth
- Table: Russia - Largest Iron Ore Projects
- Table: Russia - Iron Ore Production Forecast
Industry Risk Reward Ratings
- Risk/Reward Ratings
- Table: Mining Risk/Reward Ratings
- Russia: Mineral Wealth Fails To Hide Risks
- Kazakhstan: Weak Infrastructure Restrains Growth Potential
- Germany, Czech Republic And Slovakia: Few Rewards, Few Risks
- Ukraine: Corruption And Unexplored Potential
Regulatory Development
- Tax Regime
- Corruption To Remain Key Concern
- Table: Table: Political Overview
Commodities Forecast
- Commodity Strategy
- Steel: Weakness To Continue Over Long Term
- Aluminium: Record Stockpiles A Substantial Downside Risk
- Copper: Continued Weakness
- Lead: Autos Sector Offers Downside Cushion
- Nickel: Struggling To Find Support
- Tin: Outperforming A Weak Field
- Zinc: Tougher Ride In H213
- Table: Select Commodities - Performance & BMI Forecasts
- Table: BMI Commodity Strategy
Competitive Landscape
- Table: Russia - Largest Mining Projects
- Table: Russia - Key Financial Data For Select Listed Mining Companies
Company Profile
- SUEK
- Table: SUEK - Financial Results
- Norilsk Nickel
- Table: Norilsk Nickel - Financial Data
- Polyus Gold
- Table: Polyus Gold - Financial Data
Global Industry Overview
- Global Mining Outlook
- 1. Winners And Losers In 2013
- Table: Recent Tax Increases
- 2. China Slowdown To Weigh On Mining Equities
- 3. Capex At Risk As Prices Head Lower
- 4. Africa To Continue Attracting Chinese Attention
- 5. Changing Global Coal Trade Dynamics
- 6. Greater Industry Consolidation
- 7. New Destinations To Attract Substantial Investment
- Regional Overview
- 1. Coal: Divergent Trends Between East And West
- 2. Scandinavian Mining Production To Boom
- Table: Major Nordic Mining Projects
- 3. Greater Regulation On The Horizon
- 4. Gold Mining To Take Off In Eastern Europe
- Table: Eastern Europe - Key Gold Projects
Methodology
- Business Environment Ratings Methodology

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- Qatar's IT market is forecast to be one of the fastest growing in the Middle East over our medium term forecast to 2017. The retail market is supported by one of the highest levels of GDP per capita globally - and boosted by a strong domestic macroeconomic outlook. Meanwhile, the IT market has benefited greatly from government policy under ictQATAR's ICT-2015 strategy that is providing a platform for marked growth right across the IT market. The ambitious government investments in network infrastructure, as well as e-government and the promotion of smart systems and modernisation of enterprises will see growth not only in traditional applications but also innovative IT systems and infrastructure. This outlook extends beyond our forecast period with the decision to award Qatar the 2022 FIFA World Cup likely to support investments for several years beyond 2017.

Full Report Details at
- http://www.fastmr.com/prod/589223_qatar_information_technology_report_q2_2013.aspx?afid=101

Headline Expenditure Projections

* Computer Hardware Sales: QAR2.541bn in 2012 to QAR3.269bn in 2013, +8.6% in local currency terms. Demand for tablets and new form factors enabled by the release of Windows 8 will provide growth areas despite high PC penetration.
* Software Sales: QAR1.001bn in 2012 to QAR1.153bn in 2013, +15.2% in local currency terms. BMI expects a stronger strategic focus on software spending and hosted software.
* IT Services Sales: QAR1.591bn in 2012 to QAR1.927bn in 2017, +21.1% in local currency terms. Services are expected to be the outperforming segment of the IT market in the medium term due to demand for cloud computing and smart systems services.

Risk/Reward Ratings: Qatar's score was 59.7 out of 100.0. Qatar ranks third in our latest RRR table, behind the UAE and Israel, but ahead of Saudi Arabia and Kuwait.

Key Trends And Developments

Qatar's IT market is benefiting enormously from government spending both through ictQATAR's ICT-2015 strategy and the wider spending increase associated with its successful bid to host the 2022 FIFA World Cup. The flagship smart city project of Lusail represents the government's willingness to invest on a large scale in leading IT hardware, software and services to integrate urban management systems - offering large opportunities to a whole range of IT and telecoms enterprises. The government's investment drive as part of the diversification away from hydrocarbons has however had a wider impact that flagship projects for instance in the growth of the financial, shipping, transport and tourism sectors - all of which contribute to growth in the IT market.

The development of the National Broadband Network (Q.NBN), announced in March 2011, is continuing and working towards the target of household and business coverage of 95% of the population by fibre by 2015. The expansion of the network creates additional opportunities for hardware sales in the retail market, as well as enabling expansion of the cloud computing market.

Report Table of Contents:

BMI Industry View
SWOT
- Wireline
- Political
- Economic
- Business Environment
Industry Forecast
- Table: Qatar IT Industry - Historical Data And Forecasts (QARmn)
Macroeconomic Forecasts
- Macroeconomic Forecast
Industry Risk Reward Ratings
- Industry Rewards
- Country Rewards
- Industry Risks
- Country Risks
- Table: Middle East And Africa Risk Reward Ratings - Q213
Market Overview
- Hardware
- Software
- Services
Industry Trends And Developments
Regulatory Development
- Table: Government Authority
- ICT-2015
Company Profile
- IBM
- Microsoft Corporation
- Hewlett-Packard
- Oracle Corp
- Table: Oracle: Selected Acquisitions
Regional Overview
- MEA Regional Overview
- IT Penetration
- Sectors And Verticals
Methodology
- Methodology
- IT Industry
- IT Ratings - Methodology
- Table: IT Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
Demographic Forecast
- Table: Qatar's Population By Age Group, 1990-2020 ('000)
- Table: Qatar's Population By Age Group, 1990-2020 (% of total)
- Table: Qatar's Key Population Ratios, 1990-2020
- Table: Qatar's Rural And Urban Population, 1990-2020

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- This quarter BMI has revised and restructured its tourism reports, incorporating a greater range of data and focusing on the hotel industry, the value of the tourism industry itself, and the impact of macroeconomic factors.

The Saudi Arabia Tourism Report examines the significant long-term potential offered by the tourism industry, but highlights the potential downward pressure that regional uncertainty could have on arrival numbers as the political landscape changes. Furthermore, the country's strict entrance visa regulations also act as a constraint on the sector's long-term growth potential.

Saudi Arabia's tourist industry performed strongly in 2012. According to figures from the UN World Tourism Organisation (UNWTO) Saudi tourism receipts reportedly rose by some 14% year on year last year. Looking forward, BMI is forecasting a 7% increase in arrivals over 2013, plus a further 38.6% increase over the 2013-17 period, implying total arrivals of almost 24mn by the end of our forecast period in 2017.

Full Report Details at
- http://www.fastmr.com/prod/589236_saudi_arabia_tourism_report_q2_2013.aspx?afid=101

One of the main drivers for the tourism industry is religious visits. Saudi Arabia is home to two of Islam's holiest cities, Mecca and Medina, and every year millions of Muslims go to Mecca for the Hajj, the largest annual pilgrimage in the world. Business travel is another growth area, given Saudi Arabia's status as the world's largest oil exporter and its other large industries, such as defence.

The hospitality sector looks set to grow in tandem with tourist arrivals. BMI forecasts that there will be about 178,870 hotel rooms in Saudi Arabia by 2017, with occupancy rates increasing to 63%. In recent years, a number of international chains have opened their first hotels in the market, including Hyatt and Best Western.

Saudi Arabia will remain reliant on Middle Eastern and Asian nations for the bulk of its inbound tourism flows for the remainder of the forecast period. This is largely due to the Kingdom's strict entrance visa regulations, which can deter some non-Muslim travellers.

However, this is no bad thing for the sector's development, with these regions currently experiencing strong economic growth and rising disposable incomes, especially when compared to the stagnation seen in other regions, notably Europe.

Overall, BMI remains optimistic about the outlook for the Saudi tourism industry. The country is planning significant increases in the national room supply, while airport capacity is also set to increase rapidly.

* BMI believes that the number of hotels and other accommodation establishments in Saudi Arabia will increase across our forecast period to 2017. The country is currently offering extremely attractive investment opportunities for hotel groups and other tourist-related industries, largely due to rising domestic tourism and regional tourism, supported by an increase in higher disposable incomes.
* Among new hotel openings scheduled for Q213 is InterContinental Hotels Group's (ICHG) 506-room Crowne Plaza Medina, to be followed in Q413 by the 290-room Holiday Inn Riyadh - Meydan.
* Marriott Hotels also has two hotels scheduled to open in the coming quarter, the 129-room Courtyard by Marriott Jazan (April 2013) and the 83-room Residence Inn by Marriott Jazan (June 2013). The latter property is the first Residence brand hotel in the Kingdom.
* Starwood Hotels & Resorts is also to open two hotels in Q213, the 236-room Four Points Medina and the 356-room Sheraton Medina. Additional hotels in the development chain include the Four Points Mall of Arabia, Jeddah (opening December 2013), the Aloft Riyadh (June 2014) and the Four Points Riyadh Khaldia.
* Outbound air traffic has increased over recent years. For 2013, BMI is forecasting outbound air traffic of 20.61mn, rising to 23mn by 2017.
* This quarter, BMI has given Saudi Arabia an overall Tourism Industry Risk/Reward rating of 44.97. This puts it in tenth position for the MEA region, behind Oman and ahead of Kenya. BMI believes the Kingdom is already taking strides to improve any deficiencies in its tourism offering when compared to regional rivals, making it highly likely that Saudi Arabia's score will improve in the years ahead.

Report Table of Contents:

BMI Industry View
SWOT
- Political
- Economic
- Business Environment
Industry Forecast
- Inbound Tourism
- Table: Saudi Arabia Inbound Tourism, 2010-2017
- Table: Saudi Arabia Inbound Tourism, Top 10 markets by arrivals, 2010-2017
- Outbound Tourism
- Table: Saudi Arabia Outbound Tourism, 2010-2017
- Table: Saudi Arabia Outbound Tourism, Top 10 destinations by departures, 2010-2017
- Travel
- Table: Saudi Arabia International Tourism Receipts for Transport and Travel, 2010-2017
- Table: Saudi Arabia Breakdown of Methods of Tourist Travel
- Hotels
- Table: Saudi Arabia Hotel Accommodation, 2010-2017
Macroeconomic Forecasts
- Economic Analysis
- Table: Saudi Arabia - Economic Activity
Industry Risk Reward Ratings
- Tourism Risk Reward Ratings
- Table: MEA Risk/Rewards Ratings Table
- Security Risk Reward Ratings
- Security Risk Ratings
- Table: Middle East And Africa Defence & Security Ratings
Market Overview
- Table: Global Hotel Group Presence in Saudi Arabia
- Table: Saudi Arabia Transport Infrastructure Projects - Airports
Company Profile
- Elaf Group
Global Industry Overview
- Table: Global Tourism Indicators, International Tourist Arrivals, 2009-2017
- Table: global tourism indicators, hotel and establishment units, 2009-2017
- Table: Global Sporting Calendar, 2013-2022
Global Assumptions
- Table: Global Assumptions
- Table: Global & Regional Real GDP Growth, % chg y-o-y
- Table: Developed States - Real GDP Growth Forecasts, %
- Table: Emerging Markets - Real GDP Growth Forecasts, %
- Table: BMI VERSUS BLOOMBERG CONSENSUS REAL GDP GROWTH FORECASTS (%)
Methodology

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- We see the Saudi consumer providing good growth for the consumer electronics market, at around 5% in 2013 and rising to 6-7% in the following years of our forecast. These trends are supported by wage hikes and government investment policies. Demand in 2012 was supported by a favourable trading environment with Saudi King Abdullah's US$93bn in handouts, including wage increases, supporting spending on big-ticket lifestyle products such as smartphones and flat-screen TV sets. We expect the market to remain a key part of the Middle East's consumer electronics outlook and a key hub for vendors in the region.

Headline Expenditure Projections

* Computer Hardware Sales: US$2.2bn in 2013 to US$2.6bn by 2017. Lower PC sales growth in early 2012 still weighs on our forecast.
* AV Sales: US$3.4bn in 2013 to US$4.6bn in 2017. The latest flat-screen TVs will continue to generate strong growth in the country's outlook and maintain AV as the key component of the consumer electronics market.
* Handset Sales: US$1.2bn in 2013 to US$1.6bn by 2017 as smartphones and connected devices for internet usage gain in popularity. Vendors are bringing devices to the market more quickly than previously, catering to the strong demand for the latest developments in the market.

Full Report Details at
- http://www.fastmr.com/prod/589240_saudi_arabia_consumer_electronics_report_q2_2013.aspx?afid=101

Key Trends And Developments

Saudi Arabia's oil-rich economy has created a booming market for new consumer electronic products. Youthful population demographics, a regional economic boom and a buoyant real estate sector will all drive retail growth over the next five years. Saudi electronics retailers are reporting high footfall and strong demand for consumer electronics products, stimulated by a range of promotions on leading brands. Items in demand include smartphones and flat-screen TV sets, with screen sizes of more than 42 inches.

Trading conditions should remain favourable for retail sales of handsets. Vendors expect good sales of smartphones. Mobile subscriber penetration is forecast to pass 200% by 2017, so sales will largely be driven by the replacement market. Smartphones based on the Android operating system are expected to remain a growth area and drive the market. Android is now the most popular operating system in the Middle East ahead of RIM and Symbian.

BMI sees PC penetration rising to 35% as the consumer PC segment holds up relatively well. PC vendors and retailers will look to tablets, lower-cost ultrabooks, and the release of Microsoft's Windows 8 operating system to provide a boost to sales. Tablets should remain a growth area with new releases, the continuing preference for mobility and expanded high-speed broadband availability driving uptake.

Report Table of Contents:

BMI Industry View
SWOT
- Political
- Economic
- Business Environment
Industry Forecast
- Table: Consumer Electronics Overview
- Government Initiatives
Macroeconomic Forecasts
- Economic Analysis
- Table: Saudi Arabia - Economic Activity
Industry Risk Reward Ratings
- Industry Risk/Reward Ratings
- Table: Middle East And Africa Risk/Reward Ratings
Market Overview
- Computers
- Table: Computers - Demand
- AV Devices
- Table: AV Demand
- Mobile Devices
- Table: Mobile Handsets Demand
Competitive Landscape
- Computers
- Handsets
Industry Trends And Developments
- Table: Saudi Arabia's Distributors For Leading Brands
Company Profile
- Axiom Telecom
- Jumbo Electronics
- Eros Group
Demographic Forecast
- Table: Saudi Arabia's Population By Age Group, 1990-2020 ('000)
- Table: Saudi Arabia's Population By Age Group, 1990-2020 (% of total)
- Table: Saudi Arabia's Key Population Ratios, 1990-2020
- Table: Saudi Arabia's Rural And Urban Population, 1990-2020
Methodology
- Methodology
- Electronics Industry
- Sources

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- Mobile penetration reached 90.6% at the end of 2012, indicating significant growth potential over the medium term - in contrast to saturation across much of the region. There is also growth potential in the mobile and fixed broadband segments, particularly as a result of demand for smartphones and higher capacity fixed services bundled with TV services. Although there are strong growth prospects for much of the market, we highlight a number of changes that could disrupt the continued improvement of financial performance by operators including the arrival of MVNOs and mobile number portability.

Key Data

* Monthly blended ARPU continued to increase in 2012, with the market share weighted average up 10% y-o-y to TRY21.86 in Q412. All three operators reported increases in ARPU, in stark contrast to declining ARPU across the rest of the region.
* Decline in the fixed-line sector accelerated in 2012, with total subscriptions down 8.9% y-o-y to 13.86mn at the end of 2012, according to regulatory data.
* Smartphone ownership continued to increase as Turkcell and Vodafone reported that 17.7% and 18.9% of their respective subscription bases were smartphone users at the end of 2012, up from 11% and 14.5% at the end of 2011.

Full Report Details at
- http://www.fastmr.com/prod/589251_turkey_telecommunications_report_q3_2013.aspx?afid=101

Key Trends And Developments

The absence of independent MVNOs in Turkey has resulted in a steady stream of rumours about planned launches in recent years, including most notably the reports that Virgin Mobile was preparing to enter the market. We believe Virgin will still look to enter, but may now wait to judge the success of PTTcell, the MVNO from Turkey's Postal and Telecommunications General Directorate (PTT), which will reportedly launch in May 2013. PTTcell will initially offer prepaid services via 200 PTT branches before a nationwide retail expansion. The PTTcell network will run on Avea's network and is partially funded by the government's Universal Service Fund on the basis of an initiative to enhance rural mobile uptake. PTTcell is targeting a subscriber base of 1.5mn after one year and 5mn after two years. The creation of a vibrant MVNO market would have the effect of increasing subscription growth but place downward pressure on prices.

Turkish operators have also begun to see the potential of expanding their horizons internationally. In September 2012 Turkcell Superonline lifted boundaries between countries in the region, creating what it called 'internet without a visa' through signing direct access agreements - an initiative developed with Tata Communications, Deutsche Telekom and Inteliquent as it looks to become a regional internet traffic transport hub. Meanwhile, both Türk Telekom and Turkcell have also looked at expanding retail operations internationally by placing non-binding bids for OTE-owned Bulgarian mobile operator Globul in November 2012.

Report Table of Contents:

BMI Industry View
SWOT
- Mobile SWOT
- Wireline SWOT
- Political
- Economic
- Business Environment
Industry Forecast
- Mobile
- Table: Telecoms Sector - Mobile - Historical Data And Forecasts
- ARPU
- Table: Telecoms Sector - Mobile ARPU (TRY) - Historical Data And Forecasts
- Fixed Line
- Table: Telecoms Sector - Fixed Line - Historical Data And Forecasts
- Broadband
- Table: Telecoms Sector - Internet - Historical Data And Forecasts
Industry Risk Reward Ratings
- Industry Risk/Reward Ratings
- Industry Rewards
- Industry Risks
- Country Rewards
- Country Risks
- Table: Risk/Reward Ratings Q313
- Turkey
Market Overview
- Mobile
- Table: Turkey Mobile Market Regional Comparisons, 2012
- Mobile Growth
- Table: Turkish Mobile Market, Q412
- Table: Value-Added Services Timeline
- Mobile Operator Data
- Table: Market Overview
- Table: Turkcell
- Table: Vodafone
- Table: Avea
- Central And Eastern Europe Mobile Content
- Smartphones Drive Data Explosion
- M-Commerce Developing Rapidly
- Social Landscape Captures The Risk And Opportunities
- Fixed Line
- Broadband
- Table: Broadband Market by Technology, Subscriptions ('000), 2011-2012
- Table: TTNet Competitors - Alternative ISPs
Industry Trends And Developments
Regulatory Development
- Regulatory Overview
- Table: Turkey - Regulatory Bodies And Their Responsibilities
- Regulatory Developments
Competitive Landscape
- Table: Key Players - Turkey Telecoms Sector
Company Profile
- Türk Telekom
- Turkcell
- Vodafone Turkey
- Regional Overview
- GTS Central Europe
- Table: GTS Key Performance Indicators
- 2012 Achievements
- Future Developments
Demographic Forecast
- Table: Turkey's Population By Age Group, 1990-2020 ('000)
- Table: Turkey's Population By Age Group, 1990-2020 (% of population)
- Table: Turkey's Key Population Ratios, 1990-2020
- Table: Turkey's Rural And Urban Population, 1990-2020
Glossary
- Table: Glossary Of Terms
Methodology
- Sources

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- The accompanying tables present the latest economic data and five-year forecast scenario for the country's banking system. Also included is SWOT analysis of the commercial banking system as a whole.

Report Table of Contents:

BMI Industry View
- Table: Commercial Banking Sector Indicators
- Table: Commercial Banking Sector Key Ratios, October 2012
- Table: Annual Growth Rate Projections 2012-2017 (%)
- Table: Ranking Out Of 62 Countries Reviewed In 2013
- Table: Commercial Banking Sector Indicators, 2010-2017
SWOT
- Commercial Banking
- Political
- Economic
- Business Environment
Industry Forecast
Industry Risk Reward Ratings
- Emerging Europe Commercial Banking Risk/Reward Ratings
- Table: Emerging Europe Commercial Banking Business Environment Ratings
Market Overview
- Europe Banking Sector Outlook
- Table: Banks' Bond Portfolios, 2011
- Table: Comparison of Loan/Deposit & Loan/Asset & Loan/GDP ratios, 2013
- Table: Comparison of Total Assets & Client Loans & Client Deposits (US$bn)
- Table: Comparison of US$ Per Capita Deposits (2013)
- Economic Outlook
- Table: Ukraine - Economic Activity
Competitive Landscape
- Market Structure
- Protagonists
- Table: Protagonists In Ukraine's Commercial Banking Sector
- Table: Association of Ukrainian Banks Members
Company Profile
- PrivatBank
- Table: Stock Market Indicators
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- Ukrsotsbank
- Table: Stock Market Indicators
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- Prominvestbank
- Table: Stock Market Indicators
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- OTP Bank
- Ukreximbank
- Table: Stock Market Indicators
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- Oschadbank
- Table: Stock Market Indicators
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- Nadra Bank
- Table: Stock Market Indicators
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- VTB Bank
- Table: Stock Market Indicators
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- Alfa Bank
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
- Finance & Credit Bank
- Table: Balance Sheet (UAHmn, unless stated)
- Table: Balance Sheet (US$mn, unless stated)
- Table: Key Ratios (%)
Regional Overview
- Europe Overview
Global Industry Overview
- Global Commercial Banking Outlook
- Table: Selected Highlights Of Changes To The Formulation of the Basel III Liquid Coverage Ratio
Demographic Forecast
- Table: Ukraine's Population By Age Group, 1990-2020 ('000)
- Table: Ukraine's Population By Age Group, 1990-2020 (% of total)
- Table: Ukraine's Key Population Ratios, 1990-2020
- Table: Ukraine's Rural And Urban Population, 1990-2020
Methodology
- Table: Commercial Banking Risk/Reward Rating Indicators And Rationale
- Table: Weighting Of Indicators

Full Report Details at
- http://www.fastmr.com/prod/589259_ukraine_commercial_banking_report_q2_2013.aspx?afid=101

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- We project that US consumer electronics spending will grow by about 5% in US dollar terms in 2013, with growth areas including large-size HD TV sets, smartphones, Windows 8 tablets, ultrabooks, and smart TV sets, but questions remain about the sustainability of consumption in the absence of strong wage growth.

Flat-screen TV set sales grew strongly in January 2013, ahead of the Super Bowl, with large screen sizes in particularly demand. Meanwhile, surveys indicate increasing smartphone ownership among lower-means households, with annual incomes of US$35,000 or below. Surveys suggest returning consumer confidence, but vendors will largely rely on product innovation such as smart TV sets to drive growth. Falling average prices in many product categories will place revenue and margins under pressure.

Full Report Details at
- http://www.fastmr.com/prod/589268_united_states_consumer_electronics_report_q2_2013.aspx?afid=101

Headline Expenditure Projections

Computer hardware sales: US$149bn in 2012 to US$154bn in 2013, +3.4% in US dollar terms. Forecast in US dollar terms unchanged but Windows 8 based tablets and notebooks could provide growth areas in 2013.

AV sales: US$70bn in 2012 to US$75bn in 2013, +7% in US dollar terms. Forecast in US dollar terms unchanged because despite falling average prices in H212. There is evidence that U.S. consumers are willing to pay more for features such as 3D and large-screens.

Handset sales: US$32bn in 2012 to US$35bn in 2013, +7% in US dollar terms. Forecast in US dollar terms unchanged, with Samsung's Galaxy S4 expected to lead a fightback for Android phones following a strong performance by Apple in H212.

Risk/Reward Rating: The US's score was an unchanged 77.2 out of 100.0, giving it first place in our latest Americas CE RRR table. The country ranked first in its region for all component scores including Market, Country Structure, and Country and Market Risk. Despite its current economic challenges, BMI expects the US to retain its significance as the world's largest and most influential consumer electronics market.

Key Trends & Developments

* The average price of a flat-screen TV set in the US market dropped sharply in H212, due to increased competition, as vendors and retailers rolled out price promotions. Mature markets in many AV segments mean growth will rely to a large extent on new technologies and features to drive sales of smartphones, as well as LED, internet-enabled and 3D TV sets.
* US PC sales were forecast to report single-digit growth in 2012, after a further annualised contraction in Q212. In 2012, sales of ultrabooks fell far short of Intel's forecast that ultrabooks would comprise 40% of US notebook sales by the end of the year. Migrations to Windows 8-based devices could provide an impetus to PC upgrades in 2013, although sales of notebooks will be constrained by the growing preference for alternative connectivity devices such as tablets and smartphones.
* With the majority of telecoms operators looking to LTE for their 4G roll-outs, BMI expects consumer electronics manufacturers to concentrate on creating devices that use this technology, potentially leaving WiMAX behind in product terms. There are few LTE devices available in the market, but the number continues to increase. Greater demand for LTE equipment should allow vendors to make LTE the more cost-effective option for 4G roll-outs.

Report Table of Contents:

BMI Industry View
SWOT
- Political
- Economic
- Business Environment
Industry Forecast
- Table: Consumer Electronics Overview, 2010-2017
Macroeconomic Forecasts
- Economic Analysis
- GDP By Expenditure Breakdown
- Risks To Outlook
- Table: United States - GDP By Expenditure
Industry Risk Reward Ratings
- Industry Risk/Reward Ratings
- Table: Latin America Risk/Reward Ratings
Market Overview
- Consumer Electronics Market
- Computers
- Table: Computers, Sales, 2010-2017
- Drivers
- AV
- Table: AV Sales, 2010-2017
- TV Sets
- Digital Cameras
- Audio
- Mobile Handsets
- Table: Mobile Communications, 2010-2017
Industry Trends And Developments
- Table: US Consumer Electronics Shipments, 2010-2017
- Table: US Semiconductor Exports, 2010-2017
- Table: US Computer Exports, 2010-2017
- AV
- Table: US TV Set Exports, 2010-2017
- Telecommunications
- Table: US Telecommunications Equipment Exports, 2010-2017
Competitive Landscape
- Computer Hardware
- Handsets
- AV
Company Profile
- Apple
- Motorola Mobility
- Vizio
Demographic Forecast
- Table: The United States' Population By Age Group, 1990-2020 ('000)
- Table: The United States' Population By Age Group, 1990-2020 (% of total)
- Table: The United States' Key Population Ratios, 1990-2020
- Table: The United States' Rural And Urban Population, 1990-2020
Methodology
- Methodology
- Electronics Industry
- Sources

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- In light of Poland's increasingly depressed household segment, characterised by elevated unemployment and stagnant real wages, we do not expect a strong performance for the country's food and drinks markets in the first half of 2013. Austerity measures will further curtail public spending, and we expect private consumption to contribute only 0.7 percentage points to headline real GDP growth in 2013. However, even this figure is predicated on improvement in the eurozone situation in the second half of the year, which would boost Polish exports. Nevertheless, we remain optimistic about the longer-term consumer demand story in Poland, with the opportunities supported by its large population.

Headline Industry Data (local currency)

* 2013 per capita food consumption growth = +3.49%; forecast compound annual growth (CAGR) to 2017 = +4.95%.
* 2013 alcoholic drinks sales value growth = +4.74%; forecast CAGR to 2017 = +6.00%.
* 2013 soft drinks sales value growth = +6.65%; forecast CAGR to 2017 = +8.54%.
* 2013 mass grocery retail sales growth = +6.69%; forecast CAGR to 2017 = +7.67%.

Full Report Details at
- http://www.fastmr.com/prod/589215_poland_food_drink_report_q2_2013.aspx?afid=101

Key Industry Trends

Food Exports Keep Growing: Despite the eurozone and wider European economic weakness in 2012, Polish food exports reportedly continued to grow in 2012, rising to between EUR16.7bn-17bn, as stated by the country's Institute of Agriculture and Food Economics. Germany remained the largest recipient of Polish food exports, accounting for a 21% value share. It was followed by the UK, with 7.2%, and Russia, with 6.2%. However, annual growth in 2012, estimated at around 13%, was slower than in previous years. Poland Bans GM Crops: The cultivation of genetically modified (GM) crops has been banned in Poland as of late January 2013, despite European Food Safety Authority approval for two strains of biotech crops. Poland's Ministry of Agriculture said the reasoning behind the ban was a concern about possible cross-pollination between GM and non-GM crops.

Risks To Outlook

Eurozone To Drag On Growth: Poland's growth outlook remains highly contingent upon economic recovery in the eurozone, and while our core scenario envisages a gradual recovery in the bloc, significant downside risks remain to this view. While the odds of eurozone survival have increased since Mario Draghi's announcement that the European Central Bank would do 'whatever it takes to save the eurozone', considerable risks are still associated with the situation in the eurozone.

Partial Table of Contents:

BMI Industry View
SWOT Analysis
- Poland Food Industry SWOT
- Poland Drink Industry SWOT
- Poland Mass Grocery Retail Industry SWOT
Business Environment Ratings
- BMI's Core Global Industry Views
- Table: Core Views
- CEE Food & Drink Risk/Reward Ratings
- Table: Central & Eastern Europe Food & Drink Risk/Reward Ratings Q213
- Table: Central & Eastern Europe Food and Drink Risk/Reward Ratings Sub-components Q213 (out of 10)
- Poland Food & Drink Risk/Reward Ratings
- Macroeconomic Outlook
- Table: Economic Activity
Industry Forecast Scenario
- Consumer Outlook
- Food
- Food Consumption
- Table: Food Consumption Indicators - Historical Data & Forecasts
- Canned Food
- Table: Canned Food Value/Volume Sales - Historical Data & Forecasts
- Confectionery
- Table: Confectionery Value/Volume Sales - Historical Data & Forecasts
- Meat
- Table: Bacon & Ham Volume Sales, Production & Trade - Historical Data & Forecasts
- Fish
- Table: Fish Volume Sales, Production & Trade - Historical Data & Forecasts
- Frozen Fruit & Vegetables
- Table: Frozen Fruit & Vegetables Volume Sales, Production & Trade - Historical Data & Forecasts
- Pasta
- Table: Pasta Volume Sales, Production & Trade - Historical Data & Forecasts
- Dairy
- Table: Dairy Volume Sales, Production & Trade - Historical Data & Forecasts
- Drink
- Alcoholic Drinks
- Table: Alcoholic Drinks Value/Volume Sales - Historical Data & Forecasts
- Soft Drinks
- Table: Soft Drinks Value/Volume Sales - Historical Data & Forecasts
- Hot Drinks
- Table: Hot Drinks Value/Volume Sales - Historical Data & Forecasts
- Mass Grocery Retail
- Table: Grocery Retail Sales By Format (% of total)
- Table: Mass Grocery Retail Sales By Format - Historical Data & Forecasts
- Trade
- Table: Trade Indicators - Historical Data & Forecasts
Food
- Key Industry Trends And Developments
- Poland Bans Genetically Modified Crops
- Dairy Queen Still Rumoured to Be Interested in Entering CEE
- Food Exports Keep Growing
- Private Label Rising in Prominence
- Regional Players Make Acquisitions In Poland
- Fairtrade Products Increasing In Importance
- Market Overview
- Food Consumption
- Food Production
- Confectionery
- Canned Food
- Frozen And Chilled Food
- Trade
- Agriculture
- Meat Processing Industry
- Dairy Industry
- Organic Farming
Drink
- Key Industry Trends And Developments
- Poland World's Second Largest Producer Of Concentrated Apple Juice
- Foodcare Acquires Energy Drink
- Euro 2012 Football Competition Boosts Beverage Sales
- PepsiCo Signs Polish Distribution Deals
- Russian Standard And CEDC Create Regional Vodka Giant
- Market Overview
- Alcoholic Drinks
- Beer
- Wine
- Spirits
- Soft Drinks
- Hot Drinks
Mass Grocery Retail
- Key Industry Trends And Developments
- Jeronimo's Polish Business In Good Shape
- Market Overview
- Leading Retailers
- Table: Mass Grocery Retail Market By Estimated Number Of Outlets
Competitive Landscape
- Table: Key Players - Poland's Food Sector

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=589215&dt=t&afid=101

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- Key Insights And Key Risks

As of early 2013, the latest results that have been published by South Africa's insurance companies highlight their strengths and competitive advantages in a global context. Most have benefited from at least some of the following factors: rising demand for long-term savings products from 'retail mass' customers; development of new products; realisation of benefits of long-standing programs to boost the profitability of the products that are sold, and synergies from combinations of businesses. Unlike their counterparts in other countries, they appear to have suffered relatively little from the volatility in global financial markets. In general, they are upbeat about the prospects of (much) smaller new businesses in other countries throughout Sub-Saharan Africa (SSA).

Full Report Details at
- http://www.fastmr.com/prod/589278_south_africa_insurance_report_q2_2013.aspx?afid=101

Because of the peculiar history of South Africa, the life companies have enormous tolerance of emerging markets risk and particularly political risk. Compared with their counterparts in broadly comparable countries such as Taiwan (especially) or Israel, they have generally had to work with much smaller pools of organised savings. To a much greater extent than their Taiwanese or Israeli peers, they have built very substantial businesses in developed countries. In short, the combination of absolute size, financial strength, world-class corporate governance and orientation towards emerging and embryonic markets has served South African companies very well.

Longer-term trends in the non-life segment are less inspiring. The leading players' comments in relation to 2012 suggest that premiums will grow at single-digit rates over the year as a whole. We see no reason for non-life penetration to stop falling over the medium term. The non-life companies are working assiduously to control claims costs, boost productivity, develop new products, exploit economies of scale and, if possible, grow by acquisition. Like their counterparts in the life segment, they are looking at opportunities outside South Africa. However, for the medium term, they will likely continue to face downwards pressures on prices.

Overall, the strengths of both segments mean we are optimistic about the medium- to long-term prospects of South Africa's dynamic insurance sector. The Financial Services Board (FSB)'s solvency assessment and management (SAM) regime may require some players to strengthen their capital bases over the coming years. However, it is very difficult to imagine the problems will be insurmountable. We remain of the view that more high-profile deals, following the merger that produced MMI Holdings, could well occur.

Report Table of Contents:

BMI Industry View
- Table: Total Premiums, 2010-2017
SWOT
- Insurance
- Political
- Economic
- Business Environment
Industry Forecast
- Life
- Table: Total Life Premiums, 2010-2017
- Non Life
- Table: South Africa's Non Life Segment, 2010-2017
Market Overview
- Life Sector Update
- Non Life Sector Update
Industry Trends And Developments
- Life Growth Drivers And Risk Management Projections
- Population
- Table: Insurance Key Drivers, Demographics 2010-2017
- Non Life Growth Drivers And Risk Management Projections
- Macroeconomic Outlook
- Table: South Africa - Economic Activity, 2011-2016
- Political Stability Outlook
- Table: Middle East And Africa Defence & Security Ratings
- Healthcare
- Epidemiology
- Table: Insurance Key Drivers, Disease Adjusted Life Years 2010-2017
- Motor
- Table: Insurance Key Drivers, Autos 2010-2017
Industry Risk Reward Ratings
- South Africa Insurance Risk/Reward Ratings
- Table: South Africa's Insurance Risk/Reward Ratings
- Table: Middle East And Africa Insurance Risk/Reward Ratings
Competitive Landscape
- Competitive Landscape
Company Profile
- AIG
- Allianz
- Economic Alert
- Hollard
- Liberty Holdings
- Old Mutual
- Sanlam Group
- MMI Holdings
- Zurich South Africa
Regional Overview
- Middle East And North Africa Life Overview
- Table: Middle East And North Africa's Life Premiums, 2010-2017 (US$mn)
- Middle East And North Africa Non Life Overview
- Table: Middle East And North Africa's Non-Life Premiums, 2010-2017 (US$mn)
Demographic Forecast
- Demographic Outlook
- Table: South Africa's Population By Age Group, 1990-2020 ('000)
- Table: South Africa's Population By Age Group, 1990-2020 (% of total)
- Table: South Africa's Key Population Ratios, 1990-2020
- Table: South Africa's Rural And Urban Population, 1990-2020
Methodology
- Insurance Risk/Reward Ratings
- Table: Insurance Risk/Reward Ratings Indicators And Rationale
- Weighting
- Table: Weighting Of Indicators

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- The sharp drop in public pharmaceutical expenditure in Spain during the second half of 2012 warns of a continuing fall in spending on medicines in 2013. BMI notes that this does not bode well for drugmakers selling their products in Spain. The success of the implemented policies may encourage the enforcement of further cost-containment measures, which, with the ongoing public hospital debt situation, seriously hampers the country's attractiveness as a location in which to sell drugs, despite its favourable demographic characteristics.

Headline Expenditure Projections

* Pharmaceuticals: EUR18.34bn (US$23.30bn) in 2012 to EUR16.36bn (US$21.93bn) in 2013; -10.8% in local currency terms and -7.6% in US dollar terms.
* Healthcare: EUR102.74bn (US$130.48bn) in 2012 to EUR104.43bn (US$133.93bn) in 2013; +1.6% in local currency terms and 7.2% in US dollar terms.

Full Report Details at
- http://www.fastmr.com/prod/589131_spain_pharmaceuticals_healthcare_report_q2_2013.aspx?afid=101

Risk/Reward Ratings: In BMI's Pharmaceutical Risk/Reward Ratings (RRRs) for Q213, Spain is ranked eighth out of the 10 countries surveyed in Western Europe. While Spain offers investors positive factors, such as its large drug market, it also has problems, such as the government's focus on cost containment, low population growth, cumbersome bureaucracy and provincial differences regarding drug regulations and reimbursement.

Key Trends And Developments

* Spanish drugmaker Almirall reported full-year 2012 revenues of EUR900.2mn (US$1.17bn), a 3.1% increase from 2011 revenues of EUR873.1mn (US$1.14bn). This is positive in comparison with the 12.9% decline in revenues in 2011. Co-development agreements, co-promotion agreements and product promotion collaboration for drugs including Eklira (aclidinium bromide), Actonel (risedronate), Cipralex (escitalopram), Conbriza (bazedoxifene), Libertek (roflumilast) and Xarelto (rivaroxaban) resulted in a 107.6% increase in 'other income'. This rose from EUR104.7mn (US$135.5mn) in 2011 to EUR217.3mn (US$282.8mn) in 2012, ultimately boosting Almirall's revenues. However, we note that in 2012 the company's net sales declined by 11.1% (to EUR682.9mn, US$888.7mn), following the 12.6% decline in net sales in 2011 (to EUR768.4mn, US$1.00bn). This reveals Almirall's exposure to the Spanish government's austerity measures and the impact of patent expirations - estimated to amount to EUR136.9mn (US$177mn) in lost sales.
* On January 16 2012, the European Court of Justice ruled that Spain's decision to cut value-added tax on medical devices and some substances used in the production of medicines was illegal. The ruling means that cuts made two years ago to bring VAT to 4-10% will have to be reversed to the standard level of 21%.

BMI Economic View: With recently released estimates from the Instituto Nacional de Estadistica revealing that the Spanish economy contracted by 1.8% year-on-year (y-o-y) in real GDP terms in Q412, we reiterate our dire outlook for the Spanish economy over the next few quarters (see our online service, November 26, 'Bailout Would Provide Relief But Not A Cure'). While markets reacted positively to the European Central Bank (ECB)'s offer to buy unlimited sovereign bonds through its Outright Monetary Transaction (OMT) programme, with Spanish bond yields compressing significantly in H212, we believe this optimism is not warranted.

BMI Political View: Oli Renh, EU Commissioner for Economic and Monetary Affairs, conceded on January 29 that Spain's targets for cutting its fiscal deficit may have to be eased, after Spanish Budget Minister Cristobal Montoro signalled that the country almost certainly missed its goal of lowering the budget gap to 6.3% of GDP in 2012. Even if EU officials make a decision to relax the pace of Spain's budget consolidation, we believe fiscal austerity will continue presenting the country with a set of serious risks in 2013 and 2014, as public unrest and regional divisions build over the next few quarters.

Partial Table of Contents:

BMI Industry View
- BMI Industry View
SWOT
- Political
- Economic
- Business Environment
Industry Forecast
- Pharmaceutical Market Forecast
- Table: Spain Pharmaceutical Sales, Historical Data And Forecasts
- Healthcare Market Forecast
- Table: Spain Healthcare Expenditure Trends, Data And Forecasts
- Prescription Drug Market Forecast
- Table: Spain Prescription Drug Market Indicators, Historical Data And Forecasts
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators - Historical Data And Forecasts
- Generic Drug Market Forecast
- Table: Spain Generics Drug Market Indicators, Historical Data and Forecasts
- OTC Medicine Market Forecast
- Table: Spain OTC Medicine Market Indicators, Historical Data And Forecasts
- Pharmaceutical Trade Forecast
- Table: Spain Pharmaceutical Trade Data And Forecasts (US$mn)
- Other Healthcare Data
- Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
- Economic Analysis
- Table: Spain - Economic Activity
Industry Risk Reward Ratings
- Risk/Reward Ratings
- Table: Western Europe Pharmaceuticals And Healthcare Risk/Reward Ratings, Q213
- Rewards
- Risks
Market Overview
Industry Trends And Developments
- Epidemiology
- Healthcare Sector
- Table: Regional Public Hospital Debt - Values In EURmn
- Research & Development
- Clinical Trials
Regulatory Development
- Regulatory Regime
- Intellectual Property Issues
- Parallel Trade
- OTC Medicines
- Generic Medicines
- Pricing Regime
- Reference Pricing System
- Reimbursement Regime
Competitive Landscape
- Pharmaceutical Sector
- Generic Drug Sector
- Biotechnology Sector
- Pharmaceutical Retail
Company Profile
- Almirall
- Esteve
- GlaxoSmithKline
- Pfizer
- Novartis
- Sanofi
- Merck & Co
Demographic Forecast
- Demographic Outlook
- Table: Spain's Population By Age Group, 1990-2020 ('000)
- Table: Spain's Population By Age Group, 1990-2020 (% of total)
- Table: Spain's Key Population Ratios, 1990-2020
- Table: Spain's Rural And Urban Population, 1990-2020
Glossary
Methodology
- Methodology

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=589131&dt=t&afid=101

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- A recovery in the Spanish petrochemicals market is highly unlikely in 2013 with the probability of another year of contraction. Combined with the effects of the eurozone slowdown and increased competition from integrated facilities in the Middle East and Asia, we believe the situation create the conditions that could precipitate further closures of ageing Spanish petrochemicals units which are functioning at a far lower capacity than producers in these regions.

In 2012, the industrial production index for chemicals declined 0.7% on average while for rubber and plastic products it plummeted an average of 9.1%, compared with growth of 0.2% and -1.5% respectively in 2011. The trend in both segments was downwards, although less strong in chemicals. Nevertheless, the downturn was not as bad as BMI had anticipated in the previous quarter when we forecast a contraction of 3% in chemicals output and 10.5% in plastics and rubber.

Full Report Details at
- http://www.fastmr.com/prod/589133_spain_petrochemicals_report_q2_2013.aspx?afid=101

Over the last quarter BMI has revised the following forecasts and views:

* The pace of economic recovery and renewed growth is critical to Spain's chemicals and petrochemicals market, a significant portion of which is served by local production. With the rest of the eurozone caught up in a pronounced slowdown, Spain's capacity to export its way out of recession has disappeared entirely. We estimated GDP contracted 1.4% in 2012 and the recession should deepen in 2013 when growth should fall to -1.7%, which is far worse than the -0.2% previous forecast. Overall, 2013 could be a worse year for chemicals production while plastics are set to remain in a slump.
* The housing market continues its slump, leading to further contraction of the PVC used in construction applications. Additionally, packaging and consumer durables will be hit by high unemployment, thereby depressing demand for all grades of PE and PP. The automotive sector is also in a poor state with output having fallen by an estimated 19.6% in 2012 and set for a further five years of contraction as producers seek to relocate production activities in cheaper and high-growth regions. These conditions work against a recovery in the Spanish polymers markets.
* Spain scores 66.7 points, leaving it in sixth and last place in our Western Europe petrochemicals business environment ratings. It lies 4.9 points behind the United Kingdom.

Report Table of Contents:

BMI Industry View
SWOT
- Political
- Economic
- Business Environment
Industry Forecast
- Table: Petrochemicals Production - Historical Data & Forecasts, 2010-2017
Macroeconomic Forecast
- Macroeconomic Forecast
- Table: Spain - Economic Activity
Industry Risk/Reward Ratings
- Western Europe Petrochemicals Risk/Reward Ratings
- Risk Remains The Main Determinant Of Ratings
- Germany: The Undisputed Leader
- France: Vulnerable To A Future Downgrade
- Table: Western Europe Power Risk/Reward Ratings (Scores Out Of 100)
- Spain Petrochemicals Risk/Reward Ratings
Market Overview
- Table: Spain's Polymer Capacity
Industry Trends And Developments
- Table: Refineries In Spain
Company Profile
- Cia Espanola de Petroleos (Cepsa)
- Reysol YPF
Regional Overview
- Europe Overview
- Short-term Outlook: Competitiveness And Pricing
- Looking Beyond Europe
- Shale Gas Boom To Change European Petrochemicals Outlook?
- Commonwealth Of Independent States' Capacity Growth
Global Industry Overview
- Global Industry Overview
- Change In Feedstock, But Not In Market Cycle
- Polymers Heading On Different Trajectories
- Global Oil Product Price Outlook
- Table: BMI's Oil Price Forecasts, Average Price (US$/bbl)
- Table: BMI's Refined Products Forecasts
- Refiners: Is The Party Over?
- Jet Fuel: Middle East & Africa Remain Positive As Global Air Traffic Slumps
- Table: Total Air Freight & Passenger Volumes
- Gasoline And Diesel: Demand Destruction Takes A Toll
- Naphtha: Asia Stays Afloat While Europe Sinks
- Bunker Fuels: Trans-Pacific Route Rebound Amid High Prices
Demographic Forecast
- Demographic Outlook
- Table: Spain's Population By Age Group, 1990-2020 ('000)
- Table: Spain's Population By Age Group, 1990-2020 (% of total)
- Table: Spain's Key Population Ratios, 1990-2020
- Table: Spain's Rural And Urban Population, 1990-2020
Glossary
- Table: Glossary of Petrochemicals Terms
Methodology
- Chemicals And Petrochemicals Industry
- Cross Checks
- Risk/Reward Ratings
- Table: Petrochemicals Risk/Reward Indicators And Rationale
- Weighting
- Table: Weighting Of Indicators

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- The Egyptian economy is unlikely to stage a more pronounced recovery in the near term. Without a stabilisation in the political environment or greater clarity on medium-term policy, consumption and investment patterns will remain depressed. Nevertheless, Egypt remains one of our favourite regional markets from a longer-term point of view.

Headline Industry Forecasts (local currency)

* 2013 per capita food consumption growth = +10.43% year-on-year (y-o-y); forecast compound annual growth rate (CAGR) to 2017 = +11.52%
* 2013 alcoholic drinks value sales growth = +18.12% y-o-y; forecast CAGR to 2017 = +17.22%
* 2013 soft drinks value sales growth = +15.11% y-o-y; forecast CAGR to 2017 = +15.20%
* 2013 mass grocery retail sales growth = +14.53% y-o-y; forecast CAGR to 2017 = +15.15%

Key Industry Trends

Imports Of Kenyan Meat To Resume: In March 2013, Egypt Independent reported that meat imports from Kenya are to resume following a meeting between the two countries' veterinary authorities. Kenyan imports of frozen and live meat were originally banned in 2004 owing to concerns over quality. The resumption of imports from Kenya signifies the Egyptian government's desire to make meat more affordable to consumers by sourcing some products from cheaper manufacturing locations.

Full Report Details at
- http://www.fastmr.com/prod/589128_egypt_food_drink_report_q2_2013.aspx?afid=101

Key Risks To Outlook

Inflationary Pressure Building: A key risk is a potential spike in inflationary pressure, with a looming currency devaluation and rise in domestic energy prices likely to undermine household purchasing power. Indeed, as a result of the slightly faster than expected pace of price growth registered in February 2013, we now project consumer price inflation averaging 12.0% in 2013. Given ongoing risks of a disorderly devaluation in the Egyptian pound over the coming quarters, there is certainly a possibility that inflation could spike even higher at some stage before the end of the year.

Report Table of Contents:

BMI Industry View
SWOT
- Food
- SWOT Analysis
- Drink
- SWOT Analysis
- Mass Grocery Retail
- SWOT Analysis
Global Industry Overview
- Table: Core Views
Industry Risk/Reward Ratings
- Middle East & North Africa Food & Drink Risk/Reward Ratings
- Table: Middle East & North Africa Food & Drink Risk/Reward Ratings Q213
- Table: Middle East & North Africa Food & Drink Risk/Reward Ratings Sub-components Q213 (out of 10)
- Egypt Food & Drink Risk/Reward Ratings
- Macroeconomic Outlook
- Table: Components Of GDP By Expenditure
Industry Forecast
- Consumer Outlook
- Food
- Food Consumption
- Table: Food Consumption Indicators - Historical Data & Forecasts, 2010-2017
- Confectionery
- Table: Confectionery Value/Volume Sales - Historical Data & Forecasts, 2010-2017
- Canned Food
- Table: Canned Food Value/Volume Sales - Historical Data & Forecasts, 2010-2017
- Pasta
- Table: Pasta Volume Sales, Production & Trade - Historical Data & Forecasts, 2010-2017
- Other Processed Food
- Table: Fish Volume Sales, Production & Trade - Historical Data & Forecasts, 2010-2017
- Table: Frozen Fruit & Vegetables Volume Sales, Production & Trade - Historical Data & Forecasts, 2010-2017
- Table: Jams & Jellies Volume Sales, Production & Trade - Historical Data & Forecasts, 2010-2017
- Oils & Fats
- Table: Oils & Fats Volume Sales, Production & Trade - Historical Data & Forecasts, 2010-2017
- Drink
- Alcoholic Drinks
- Table: Alcoholic Drinks Value/Volume Sales, Production & Trade - Historical Data & Forecasts, 2010-2017
- Soft Drinks
- Table: Soft Drinks Value/Volume Sales - Historical Data & Forecasts, 2010-2017
- Hot Drinks
- Table: Hot Drinks Volume Sales, Production & Trade - Historical Data & Forecasts, 2010-2017
- Mass Grocery Retail
- Table: Grocery Retail Sales By Format, %
- Table: Mass Grocery Retail Sales - Historical Data & Forecasts, 2010-2017
- Trade
- Table: Trade Indicators - Historical Data & Forecasts, 2010-2017
Food
- Key Industry Trends And Developments
- Imports Of Kenyan Meat To Resume
- Western Restaurants Prompt Casual Dining Expansion
- Nestle Increases Investment In Egypt
- Foreign Interest Growing
- Domestic Companies Pursuing Local Expansion
- Market Overview
- Food Processing
- Confectionery
- Trade
- Agriculture
- Dairy
- Sugar Processing
- Halal Food
Drink
- Key Industry Trends And Developments
- Taxes On Beer Increase By 200%
- Local Leaders Investing In Diversification And Capacity Expansion
- Cutting Down Tourism Reliance In Alcohol Sales
- Multinational Interest Growing
- Market Overview
- Alcoholic Drinks
- Soft Drinks
- Hot Drinks
Mass Grocery Retail
- Key Industry Trends And Developments
- Investment Interest Growing Slowly
- Carrefour MAF Continues Expanding
- Makro Looks To Export Egyptian Produce
- Market Overview
- Leading Retailers
Competitive Landscape
- Table: Key Players In Egypt's Food Sector
- Table: Key Players In Egypt's Drink Sector
- Table: Key Players In Egypt's Mass Grocery Retail Industry
Company Profile
- Food
- Cairo Poultry Company
- Faragalla
- Cadbury Egypt
- Drink
- Al-Ahram Beverages Co (Heineken)
- Egypt Bottling Company (PepsiCo)
- Coca-Cola Bottling Company Of Egypt
- Mass Grocery Retail
- Metro (Mansour Group)
- Carrefour MAF
- Spinneys Group
Demographic Forecast
- Table: Egypt's Population By Age Group, 1990-2020 ('000)
- Table: Egypt's Population By Age Group, 1990-2020 (% of total)
- Table: Egypt's Key Population Ratios, 1990-2020
- Table: Egypt's Rural And Urban Population, 1990-2020
Methodology
- Table: Rewards
- Table: Risks
- Weighting
- Table: Weighting
Glossary
- Food & Drink
- Mass Grocery Retail

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

(PRBuzz.com) May 8, 2013 -- The Kuwait Retail Report examines the long-term potential of the local consumer market, but flags shortterm concerns about the impact on Kuwait's economic outlook of depressed capital spending on the part of the government.

The report examines how best to maximise returns in the Kuwaiti retail market while minimising investment risk, and also explores the impact of the possibility of oil prices declining further than expected on the Kuwaiti consumer and on the ability of producers and exporters to realise returns in the short term.

The report also analyses the growth and risk management strategies being employed by the leading players in the Kuwaiti retail sector, as they seek to maximise the growth opportunities offered by the local market. Kuwait comes fourth (out of seven) in BMI's Middle East and Africa (MEA) Retail Risk/Reward Ratings, although it underperforms slightly for risk.

Full Report Details at
- http://www.fastmr.com/prod/589189_kuwait_retail_report_q2_2013.aspx?afid=101

Among all retail categories, consumer electronics will be one of the outperformers between 2013 and 2017 in growth terms, with sales forecast to increase by almost 29% from US$1.10bn to US$1.42bn, on the back of a high-earning, tech-literate population. In the competitive arena, BMI sees upside potential in trade liberalisation, with the elimination of customs duties within the Gulf Cooperation Council continuing to stimulate the market; and in telecoms deregulation and 3G expansion, which will drive competition in value-added services and support spending levels on handsets.

Over the last quarter, BMI has revised the following forecasts/views:

* BMI expects the Kuwaiti economy to perform relatively well over 2013, but at a more modest pace than in recent years, with economic growth driven by robust domestic consumption, but dragged down by a plateau in oil production and exports. BMI's Oil & Gas team projects Kuwaiti oil production to grow by only 0.3% in 2013, with flat growth in exports as a result. Accordingly, we have revised downward our real GDP forecast for the year to 3.0% (from 3.7% previously), although we note the presence of a sizeable upside risk, in the form of the government's newfound domination of the legislative branch.
* Indicators of consumer sentiment are positive on the whole, with the YouGov/Bayt.com Consumer Confidence Index reaching 88.4 in October 2012, broadly unchanged from the rest of the year (although a modest sample size limits the index's usefulness). Point-of-sale and ATM transactions rose by a respective 19.2% and 7.9% year-on-year in Q312, according to data from the Central Bank of Kuwait. We forecast household consumption to grow by 3.5% in 2013, providing a boost of approximately 1% to the headline GDP figure.

Report Table of Contents:

BMI Industry View
- BMI Industry View
SWOT
- SWOT
- Political
- Economic
Industry Forecast
- Industry Forecast Scenario
- Table: Retail Sales Indicators, 2010-2017
- Table: Retail Sales Breakdown By Key Segment, 2013f
Macroeconomic Forecasts
- Macroeconomic Forecast
- Table: Kuwait - Economic Activity
Industry Risk Reward Ratings
- Middle East And Africa Risk/Reward Ratings
- Table: Middle East And Africa Regional Retail Risk/Reward Ratings
- Kuwait Risk/Reward Ratings
- Limits To Potential Returns
- Risks To Realisation Of Returns
Market Overview
- Current Trends
- Key Players
Regional Overview
- Middle East And Africa Overview
- Table: Middle East And Africa Retail Trends, 2010-2017
- Table: Middle East And Africa Regional Retail Sales, 2010-2017 (US$bn)
- Table: Share Of Regional Retail Sales, 2010-2017 (%)
- Current Trends
- Mass Grocery Retail
- Mass Retail Grocery
- Industry Forecast
- Table: Mass Grocery Retail Sales Value By Format - Historical Data & Forecasts, 2010-2017
- Table: Grocery Retail Sales By Format
- Market Overview
- Table: Mass Grocery Retail Market Share By Retailer - 2012 Estimate
- Table: Structure Of Mass Grocery Retail Market By Number Of Outlets
- Table: Structure Of Mass Grocery Retail Market - Sales Value By Format (US$bn)
- Table: Structure Of Kuwait's Mass Grocery Retail Market - Sales Value By Format (KWTbn)
- Table: Estimated Value Of Sales Per Outlet, 2012
Autos
- SWOT
- Industry Forecast
- Table: Kuwait - Top 10 Best-Selling Models, 2012
- Luxury Cars
- Suppliers
- Leasing
Consumer Electronics
- SWOT
- Industry Forecast
- Table: Consumer Electronics Overview, 2010-2017
- Market Overview
- Computers
- Table: PC Sales, 2010-2017
- AV
- Table: AV Sales, 2010-2017
- Mobile Handsets
- Table: Mobile Communications, 2010-2017
Demographic Forecast
- Table: Kuwait's Population By Age Group, 1990-2020 ('000)
- Table: Kuwait's Population By Age Group, 1990-2020 (% of total)
- Table: Kuwait's Key Population Ratios, 1990-2020
- Table: Kuwait's Rural And Urban Population, 1990-2020
Methodology
- Sources

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Dr. B Well Chiropractic Health and Wellness, Dr. Barry Heffron
516-764-2222
www.drb-well.com

Rockville Centre, NY's Dr. B Well Chiropractic Health and Wellness Treats Auto Accident Injuries

The days and weeks following an auto accident can be stressful. Between managing car damage and insurance claims, personal injury care can fall by the wayside. However, even minor accidents can result in serious injuries. At Dr. B Well Chiropractic Health and Wellness, Rockville Centre, NY patients are evaluated for both hard and soft tissue damage that could present problems over time. If you or someone you know has recently been in an auto accident, Dr. Barry Heffron stresses the importance of seeking chiropractic care to prevent and relieve pain from underlying injuries.

Chiropractic care focuses on treating and caring for soft tissue injuries. This includes the muscles, nerves and tendons throughout the body. When our muscles tense to brace for the impact of an accident, it can leave us feeling sore. Dr. B Well Chiropractic Health and Wellness focuses on understanding the connections between our body's soft tissues. When one area suffers an injury, it can cause pain and discomfort in another. The most common auto accident injury is whiplash. While this condition may not be immediately painful, it tends to develop over the days following an accident. As your neck tenses during an accident, your body is still moving forward. Dr. Barry Heffron helps patients relieve this tension in the neck, shoulders, lower back and other areas that may be affected by even minor accidents.

For those that live in or around the Rockville Centre, NY area and have recently been in an auto accident, chiropractic care can address your injuries in a safe, non-invasive way. Dr. B Well Chiropractic Health and Wellness helps patients recover from their injuries and prevent future issues from arising. Although auto accidents can be stressful, Dr. Barry Heffron reminds patients that it is important to care for your health with chiropractic care.

For more information on the chiropractic treatments available at Dr. B Well Chiropractic Health and Wellness in Rockville Centre, NY, visit www.drb-well.com or call 516-764-2222 to schedule an appointment with Dr. Barry Heffron.